Knockdown of circMYBL2 accelerated apoptosis and inhibited proliferation of AML cells resistant to quizartinib, a selective and efficient FLT3 inhibitor, indicating circMYBL2 inducing quizartinib resistance in AML [25]. This evidence concerns the gene FLT3 and acute myeloid leukemia.